Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1,800,000 Profiles
More than 3,500 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Jerome Belinson

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Neoplasm Drug Resistance

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
46
Markman, Maurie
34
Kulp, Barbara
33
Peterson, Gertrude
32
Webster, Kenneth
25
Zanotti, Kristine
17
Kennedy, Alexander
17
Kennedy, A
14
Qiao, You-Lin
13
Pretorius, Robert
9
Xu, Yan
8
Zhang, Wen-hua
8
Escobar, Pedro
7
Casey, Graham
7
Elson, Paul
7
Webster, Kenneth

Sign-in to see all Coauthors

Publications

TOP 3
Farley John; Fuchiuji Sartoru; Darcy Kathleen M; Tian Chunqiao; Hoskins William J; McGuire William P; Hanjani Parviz; Warshal David; Greer Benjamin E; Belinson Jerome; Birrer Michael J
Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gynecologic Oncology Group Study.
Fader A Nickles; Michener C M; Frasure H E; Giannios N; Belinson J L; Zanotti K M
Total laparoscopic hysterectomy versus laparoscopic-assisted vaginal hysterectomy in endometrial cancer: surgical and survival outcomes.
Li Jing; Li Lian-Kun; Ma Jun-Fei; Wei Li-Hui; Niyazi Mayinuer; Li Chang-Qing; Xu Ai-Di; Wang Jian-Bin; Liang Hao; Belinson Jerome; Qiao You-Lin
Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jerome Belinson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Farley John; Fuchiuji Sartoru; Darcy Kathleen M; Tian Chunqiao; Hoskins William J; McGuire William P; Hanjani Parviz; Warshal David; Greer Benjamin E; Belinson Jerome; Birrer Michael J
Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gynecologic Oncology Group Study.
Gynecologic oncology 2009;113(3):341-7.
2009: Fader A Nickles; Michener C M; Frasure H E; Giannios N; Belinson J L; Zanotti K M
Total laparoscopic hysterectomy versus laparoscopic-assisted vaginal hysterectomy in endometrial cancer: surgical and survival outcomes.
Journal of minimally invasive gynecology 2009;16(3):333-9.
2009: Li Jing; Li Lian-Kun; Ma Jun-Fei; Wei Li-Hui; Niyazi Mayinuer; Li Chang-Qing; Xu Ai-Di; Wang Jian-Bin; Liang Hao; Belinson Jerome; Qiao You-Lin
Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China.
Vaccine 2009;27(8):1210-5.
2008: Belinson Suzanne; Smith Jennifer S; Myers Evan; Olshan Andrew; Belinson Jerome; Pretorius Robert; Qiao You-lin; Hartmann Katherine
Descriptive evidence that risk profiles for cervical intraepithelial neoplasia 1, 2, and 3 are unique.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(9):2350-5.
2008: Yang Bin; Pretorius Robert G; Belinson Jerome L; Zhang Xun; Burchette Raoul; Qiao You-Lin
False negative colposcopy is associated with thinner cervical intraepithelial neoplasia 2 and 3.
Gynecologic oncology 2008;110(1):32-6.
2008: Sengupta Saubhik; Michener Chad M; Escobar Pedro; Belinson Jerome; Ganapathi Ram
Ovarian cancer immuno-reactive antigen domain containing 1 (OCIAD1), a key player in ovarian cancer cell adhesion.
Gynecologic oncology 2008;109(2):226-33.
2008: Fader Amanda Nickles; von Gruenigen Vivian; Gibbons Heidi; Abushahin Fadi; Starks David; Markman Maurie; Belinson Jerome; Rose Peter
Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients.
Gynecologic oncology 2008;109(1):33-8.
2007: Pretorius Robert G; Belinson Jerome L
Letter to the editor concerning Petignat et al.'s "Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis." Gynecol Oncol 2007;105(2): 530-535.
Gynecologic oncology 2007;107(3):595-6; author reply 596-7.
2007: Pretorius Robert G; Bao Yan-Ping; Belinson Jerome L; Burchette Raoul J; Smith Jennifer S; Qiao You-Lin
Inappropriate gold standard bias in cervical cancer screening studies.
International journal of cancer. Journal international du cancer 2007;121(10):2218-24.
2007: Zhao Chao; Li Jing; Tu Zheng; Song Dan; Cui Shu-hui; Zhang Wen-hua; Qiao You-lin; Wang Jian-liu; Belinson Jerome; Wei Li-hui
[Study on the correlation between human papillomavirus infection and cervical lesion among women living in community of Beijing]
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 2007;28(10):947-50.
2007: Simpkins Fiona; Belinson Jerome L; Rose Peter G
Avoiding bevacizumab related gastrointestinal toxicity for recurrent ovarian cancer by careful patient screening.
Gynecologic oncology 2007;107(1):118-23.
2007: Sengupta S; Kim K S; Berk M P; Oates R; Escobar P; Belinson J; Li W; Lindner D J; Williams B; Xu Y
Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion.
Oncogene 2007;26(20):2894-901.
2006: Escobar P F; Rojas-Espaillat L; Tisci S; Enerson C; Brainard J; Smith J; Tresser N J; Feldchtein F I; Rojas L B; Belinson J L
Optical coherence tomography as a diagnostic aid to visual inspection and colposcopy for preinvasive and invasive cancer of the uterine cervix.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(5):1815-22.
2006: Kim Kwan-Sik; Sengupta Saubhik; Berk Michael; Kwak Yong-Geun; Escobar Pedro F; Belinson Jerome; Mok Samuel C; Xu Yan
Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo.
Cancer research 2006;66(16):7983-90.
2006: Belinson Jerome L
Are screen-and-treat approaches effective for cervical cancer prevention?
Nature clinical practice. Oncology 2006;3(6):296-7.
2006: Kebria Mehdi M; Belinson Jerome; Kim Robert; Mekhail Tarek M
Malignant acanthosis nigricans, tripe palms and the sign of Leser-Tre'lat, a hint to the diagnosis of early stage ovarian cancer: a case report and review of the literature.
Gynecologic oncology 2006;101(2):353-5.
2006: Pretorius Robert G; Zhang Xun; Belinson Jerome L; Zhang Wen-Hua; Ren Shen-Da; Bao Yan-Ping; Qiao You-Lin
Distribution of cervical intraepithelial neoplasia 2, 3 and cancer on the uterine cervix.
Journal of lower genital tract disease 2006;10(1):45-50.
2006: Pretorius Robert G; Kim Robert J; Belinson Jerome L; Elson Paul; Qiao You-Lin
Inflation of sensitivity of cervical cancer screening tests secondary to correlated error in colposcopy.
Journal of lower genital tract disease 2006;10(1):5-9.
2006: Zhao Fang-Hui; Forman Michele R; Belinson Jerome; Shen Yan-hong; Graubard Barry I; Patel Arti C; Rong Shou-de; Pretorius Robert G; Qiao You-lin
Risk factors for HPV infection and cervical cancer among unscreened women in a high-risk rural area of China.
International journal of cancer. Journal international du cancer 2006;118(2):442-8.
2005: Michener Chad M; Belinson Jerome L
Modern management of recurrent ovarian carcinoma. A systematic approach to a chronic disease.
Oncology (Williston Park, N.Y.) 2005;19(10):1277-85; discussion 1285, 1288, 1293.
2005: Escobar P F; Rojas-Espaillat L; Belinson J L
Optical diagnosis of cervical dysplasia.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2005;89(1):63-4.
2005: Markman Maurie; Belinson Jerome
A rationale for neoadjuvant systemic treatment followed by surgical assessment and intraperitoneal chemotherapy in patients presenting with non-surgically resectable ovarian or primary peritoneal cancers.
Journal of cancer research and clinical oncology 2005;131(1):26-30.
2004: Markman Maurie; Markman Jon; Webster Kenneth; Zanotti Kristine; Kulp Barbara; Peterson Gertrude; Belinson Jerome
Thrombocytopenia associated with second-line carboplatin-based chemotherapy for ovarian, fallopian tube, and primary peritoneal cavity cancers.
Journal of cancer research and clinical oncology 2004;130(12):741-4.
2004: Green Andrew E; Biscotti Charles; Michener Chad; Belinson Jerome
Isolated cervical metastasis of breast cancer: a case report and review of the literature.
Gynecologic oncology 2004;95(1):267-9.
2004: Markman Maurie; Webster Kenneth; Zanotti Kristine; Kulp Barbara; Peterson Gertrude; Belinson Jerome
Phase 2 trial of prolonged administration of oral topotecan in platinum/taxane-refractory ovarian, fallopian tube, and primary peritoneal cancers.
Gynecologic oncology 2004;95(1):109-13.
2004: Pretorius Robert G; Zhang Wen-Hua; Belinson Jerome L; Huang Man-Ni; Wu Ling-Ying; Zhang Xun; Qiao You-Lin
Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse.
American journal of obstetrics and gynecology 2004;191(2):430-4.
2004: Markman Maurie; Webster Kenneth; Zanotti Kristine; Peterson Gertrude; Kulp Barbara; Belinson Jerome
Phase 2 trial of carboplatin plus tamoxifen in platinum-resistant ovarian cancer and primary carcinoma of the peritoneum.
Gynecologic oncology 2004;94(2):404-8.
2004: Markman Maurie; Markman Jonathan; Webster Kenneth; Zanotti Kristine; Kulp Barbara; Peterson Gertrude; Belinson Jerome
Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(15):3120-5.
2004: Uyar Denise; Kulp Barbara; Peterson Gertrude; Zanotti Kristine; Markman Maurie; Belinson Jerome
Cardiac safety profile of prolonged (>or=6 cycles) pegylated liposomal doxorubicin administration in patients with gynecologic malignancies.
Gynecologic oncology 2004;94(1):147-51.
2004: Markman Maurie; Webster Kenneth; Zanotti Kristine; Peterson Gertrude; Kulp Barbara; Belinson Jerome
Examples of the marked variability in the relationship between the serum CA-125 antigen level and cancer-related symptoms in ovarian cancer.
Gynecologic oncology 2004;93(3):715-7.
2004: Markman Maurie; Webster Kenneth; Zanotti Kristine; Peterson Gertrude; Kulp Barbara; Belinson Jerome
Survival following the documentation of platinum and taxane resistance in ovarian cancer: a single institution experience involving multiple phase 2 clinical trials.
Gynecologic oncology 2004;93(3):699-701.
2004: Escobar P F; Belinson J L; White A; Shakhova N M; Feldchtein F I; Kareta M V; Gladkova N D
Diagnostic efficacy of optical coherence tomography in the management of preinvasive and invasive cancer of uterine cervix and vulva.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2004;14(3):470-4.
2004: Markman Maurie; Webster Kenneth; Zanotti Kristine; Rohl Jacqueline; Belinson Jerome
Use of tamoxifen in asymptomatic patients with recurrent small-volume ovarian cancer.
Gynecologic oncology 2004;93(2):390-3.
2004: Markman Jonathan; Zanotti Kristine; Webster Kenneth; Belinson Jerome; Peterson Gertrude; Kulp Barbara; Markman Maurie
Experience with the management of neutropenia in gynecologic cancer patients receiving carboplatin-based chemotherapy.
Gynecologic oncology 2004;92(2):592-5.
2004: Escobar Pedro F; Markman Maurie; Rose Peter; Zanotti Kristine; Webster Kenneth; Belinson Jerome
Phase 2 trial of carboplatin, paclitaxel, and irinotecan in ovarian, fallopian tube, and primary peritoneal cancers.
Gynecologic oncology 2004;92(1):192-6.
2004: Markman Maurie; Hsieh Fred; Zanotti Kristine; Webster Kenneth; Peterson Gertrude; Kulp Barbara; Spicel Ann; Belinson Jerome
Initial experience with a novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin-hypersensitivity reactions.
Journal of cancer research and clinical oncology 2004;130(1):25-8.
2004: Markman Maurie; Belinson Jerome; Webster Kenneth; Zanotti Kristine; Morrison Bei; Jacobs Barbara; Borden Ernest; Lindner Daniel
Phase 2 trial of interferon-beta as second-line treatment of ovarian cancer, fallopian tube cancer, or primary carcinoma of the peritoneum.
Oncology 2004;66(5):343-6.
2003: Markman Maurie; Zanotti Kristine; Webster Kenneth; Peterson Gertrude; Kulp Barbara; Belinson Jerome
Phase 2 trial of single agent docetaxel in platinum and paclitaxel-refractory ovarian cancer, fallopian tube cancer, and primary carcinoma of the peritoneum.
Gynecologic oncology 2003;91(3):573-6.
2003: Markman Maurie; Zanotti Kristine; Peterson Gertrude; Kulp Barbara; Webster Kenneth; Belinson Jerome
Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4611-4.
2003: Belinson J L; Qiao Y L; Pretorius R G; Zhang W H; Rong S D; Huang M N; Zhao F H; Wu L Y; Ren S D; Huang R D; Washington M F; Pan Q J; Li L; Fife D
Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2003;13(6):819-26.
2003: Escobar Pedro F; Markman Maurie; Zanotti Kristine; Webster Kenneth; Belinson Jerome
Phase 2 trial of pegylated liposomal doxorubicin in advanced endometrial cancer.
Journal of cancer research and clinical oncology 2003;129(11):651-4.
2003: Markman Maurie; Elson Paul; Kulp Barb; Peterson Gertrude; Zanotti Kristine; Webster Kenneth; Belinson Jerome
Carboplatin plus paclitaxel combination chemotherapy: impact of sequence of drug administration on treatment-induced neutropenia.
Gynecologic oncology 2003;91(1):118-22.
2003: Markman Maurie; Webster Kenneth; Zanotti Kristine; Kulp Barbara; Peterson Gertrude; Belinson Jerome
Phase 2 trial of single-agent gemcitabine in platinum-paclitaxel refractory ovarian cancer.
Gynecologic oncology 2003;90(3):593-6.
2003: Markman Maurie; Zanotti Kristine; Webster Kenneth; Belinson Jerome; Rose Peter
Toxicity associated with carboplatin/paclitaxel/Irinotecan use in advanced ovarian cancer: preliminary analysis.
Oncology (Williston Park, N.Y.) 2003;17(5 Suppl 5):34-5.
2003: Xu Yan; Xiao Yi-Jin; Zhu Kui; Baudhuin Linnea M; Lu Jun; Hong Guiying; Kim Kwan-Sik; Cristina Kelly L; Song Li; S Williams Freager; Elson Paul; Markman Maurie; Belinson Jerome
Unfolding the pathophysiological role of bioactive lysophospholipids.
Current drug targets. Immune, endocrine and metabolic disorders 2003;3(1):23-32.
2003: Pan Qinjing; Belinson Jerome L; Li Ling; Pretorius Robert G; Qiao You Lin; Zhang Wen Hua; Zhang Xun; Wu Ling Ying; Rong Sou De; Sun Yun Tian
A thin-layer, liquid-based pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A cross-sectional, comparative study.
Acta cytologica 2003;47(1):45-50.
2002: Zanotti Kristine M; Belinson Jerome
Update on the diagnosis and treatment of human papillomavirus infection.
Cleveland Clinic journal of medicine 2002;69(12):948, 951-5, 956 passim.
2002: Markman Maurie; Kulp Barbara; Peterson Gertrude; Kennedy Alexander; Belinson Jerome
Second-line therapy of ovarian cancer with Paclitaxel administered by both the intravenous and intraperitoneal routes: rationale and case reports.
Gynecologic oncology 2002;86(1):95-8.
2002: Belinson Jerome L; Pan Qiong-Jing; Biscotti Charles; Wu Ling-Ying; Pretorius Robert G; Li Ling; Elson Paul; Rong Shou-De; Zhang Wen-Hua; Qiao You-Lin
Primary screening with liquid-based cytology in an unscreened population in rural China, with an emphasis on reprocessing unsatisfactory samples.
Acta cytologica 2002;46(3):470-4.
2001: Belinson J; Qiao Y L; Pretorius R; Zhang W H; Elson P; Li L; Pan Q J; Fischer C; Lorincz A; Zahniser D
Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia.
Gynecologic oncology 2001;83(2):439-44.
2001: Mahmoud-Ahmed A S; Suh J H; Barnett G H; Webster K D; Belinson J L; Kennedy A W
The effect of radiation therapy on brain metastases from endometrial carcinoma: a retrospective study.
Gynecologic oncology 2001;83(2):305-9.
2001: Shen Z; Wu M; Elson P; Kennedy A W; Belinson J; Casey G; Xu Y
Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases.
Gynecologic oncology 2001;83(1):25-30.
2001: Belinson J L; Pretorius R G; Zhang W H; Wu L Y; Qiao Y L; Elson P
Cervical cancer screening by simple visual inspection after acetic acid.
Obstetrics and gynecology 2001;98(3):441-4.
2001: Pretorius R G; Belinson J L; Zhang W H; Burchette R J; Elson P; Qiao Y L
The colposcopic impression. Is it influenced by the colposcopist's knowledge of the findings on the referral Papanicolaou smear?
The Journal of reproductive medicine 2001;46(8):724-8.
2001: Zanotti K M; Rybicki L A; Kennedy A W; Belinson J L; Webster K D; Kulp B; Peterson G; Markman M
Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(12):3126-9.
2001: Markman M; Kennedy A; Webster K; Peterson G; Kulp B; Belinson J
Combination chemotherapy with carboplatin and docetaxel in the treatment of cancers of the ovary and fallopian tube and primary carcinoma of the peritoneum.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(7):1901-5.
2001: Xiao Y J; Schwartz B; Washington M; Kennedy A; Webster K; Belinson J; Xu Y
Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids.
Analytical biochemistry 2001;290(2):302-13.
2001: Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
Neurotoxicity associated with a regimen of carboplatin (AUC 5-6) and paclitaxel (175 mg/m2 over 3 h) employed in the treatment of gynecologic malignancies.
Journal of cancer research and clinical oncology 2001;127(1):55-8.
2000: Zanotti K M; Belinson J L; Kennedy A W
Treatment of gynecologic cancers in pregnancy.
Seminars in oncology 2000;27(6):686-98.
2000: Zanotti K M; Belinson J L; Kennedy A W; Webster K D; Markman M
Treatment of relapsed carcinoma of the ovary with single-agent paclitaxel following exposure to paclitaxel and platinum employed as initial therapy.
Gynecologic oncology 2000;79(2):211-5.
2000: Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
Phase 2 evaluation of topotecan administered on a 3-day schedule in the treatment of platinum- and paclitaxel-refractory ovarian cancer.
Gynecologic oncology 2000;79(1):116-9.
2000: Markman M; Kennedy A; Webster K; Peterson G; Kulp B; Belinson J
Phase 2 trial of liposomal doxorubicin (40 mg/m(2)) in platinum/paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum.
Gynecologic oncology 2000;78(3 Pt 1):369-72.
2000: Kushner D M; Webster K D; Belinson J L; Rybicki L A; Kennedy A W; Markman M
Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma.
Gynecologic oncology 2000;78(2):221-7.
2000: Markman M; Kennedy A; Webster K; Peterson G; Kulp B; Belinson J
The antiemetic efficacy of oral ondansetron plus intravenous dexamethasone in patients with gynecologic malignancies receiving carboplatin-based chemotherapy.
Gynecologic oncology 2000;78(1):43-6.
2000: Markman M; Kennedy A; Webster K; Peterson G; Kulp B; Belinson J
Experience with prophylactic oral ciprofloxacin in gynecological cancer patients developing severe chemotherapy-induced neutropenia.
Journal of cancer research and clinical oncology 2000;126(5):298-300.
2000: Markman M; Kennedy A; Webster K; Peterson G; Kulp B; Belinson J
Declining CA-125 in an ovarian cancer patient with progression of measurable disease: a rational hypothesis for discordant results.
Gynecologic oncology 2000;77(2):321-2.
2000: Xiao Y; Chen Y; Kennedy A W; Belinson J; Xu Y
Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses.
Annals of the New York Academy of Sciences 2000;905():242-59.
2000: Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(1):102-5.
1999: Abramovich D; Markman M; Kennedy A; Webster K; Belinson J
Serum CA-125 as a marker of disease activity in uterine papillary serous carcinoma.
Journal of cancer research and clinical oncology 1999;125(12):697-8.
1999: Stagno S J; Forster H; Belinson J
Medical and osteopathic boards' positions on chaperones during gynecologic examinations.
Obstetrics and gynecology 1999;94(3):352-4.
1999: Zanotti K M; Belinson J L; Kennedy A W; Webster K D; Markman M
The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma.
Gynecologic oncology 1999;74(2):272-7.
1999: Zanotti K M; Hart W R; Kennedy A W; Belinson J L; Casey G
Allelic imbalance on chromosome 17p13 in borderline (low malignant potential) epithelial ovarian tumors.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1999;18(3):247-53.
1999: Markman M; Kennedy A; Webster K; Peterson G; Kulp B; Belinson J
An effective and more convenient drug regimen for prophylaxis against paclitaxel-associated hypersensitivity reactions.
Journal of cancer research and clinical oncology 1999;125(7):427-9.
1999: Weber A M; Belinson J L; Piedmonte M R
Risk factors for endometrial hyperplasia and cancer among women with abnormal bleeding.
Obstetrics and gynecology 1999;93(4):594-8.
1999: Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
Use of low-dose oral prednisone to prevent paclitaxel-induced arthralgias and myalgias.
Gynecologic oncology 1999;72(1):100-1.
1998: Shen Z; Belinson J; Morton R E; Xu Y; Xu Y
Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells.
Gynecologic oncology 1998;71(3):364-8.
1998: Kennedy A W; Markman M; Webster K D; Kulp B; Peterson G; Rybicki L A; Belinson J L
Experience with platinum-paclitaxel chemotherapy in the initial management of papillary serous carcinoma of the peritoneum.
Gynecologic oncology 1998;71(2):288-90.
1998: Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
Low-dose oral granisetron (1 mg) plus intravenous dexamethasone: efficacy in gynecologic cancer patients receiving carboplatin-based chemotherapy.
Gynecologic oncology 1998;71(1):113-5.
1998: Wiper D W; Zanotti K M; Kennedy A W; Belinson J L; Casey G
Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers.
Gynecologic oncology 1998;71(1):77-82.
1998: Markman M; Kennedy A; Sutton G; Hurteau J; Webster K; Peterson G; Kulp B; Belinson J
Phase 2 trial of single agent ifosfamide/mesna in patients with platinum/paclitaxel refractory ovarian cancer who have not previously been treated with an alkylating agent.
Gynecologic oncology 1998;70(2):272-4.
1998: Xu Y; Shen Z; Wiper D W; Wu M; Morton R E; Elson P; Kennedy A W; Belinson J; Markman M; Casey G
Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers.
JAMA : the journal of the American Medical Association 1998;280(8):719-23.
1998: Markman M; Rose P G; Jones E; Horowitz I R; Kennedy A; Webster K; Belinson J; Fusco N; Fluellen L; Kulp B; Peterson G; McGuire W P
Ninety-six-hour infusional paclitaxel as salvage therapy of ovarian cancer patients previously failing treatment with 3-hour or 24-hour paclitaxel infusion regimens.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1849-51.
1998: Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
Evidence that a "treatment-free interval of less than 6 months" does not equate with clinically defined platinum resistance in ovarian cancer or primary peritoneal carcinoma.
Journal of cancer research and clinical oncology 1998;124(6):326-8.
1997: Weber A M; Belinson J L; Bradley L D; Piedmonte M R
Vaginal ultrasonography versus endometrial biopsy in women with postmenopausal bleeding.
American journal of obstetrics and gynecology 1997;177(4):924-9.
1997: Eltabbakh G H; Belinson J L; Kennedy A W; Gupta M; Webster K; Blumenson L E
Serum CA-125 measurements > 65 U/mL. Clinical value.
The Journal of reproductive medicine 1997;42(10):617-24.
1997: Eltabbakh G H; Belinson J L; Kennedy A W; Biscotti C V; Casey G; Tubbs R R; Blumenson L E
p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer.
Cancer 1997;80(5):892-8.
1997: Eltabbakh G H; Belinson J L; Kennedy A W; Biscotti C V; Casey G; Tubbs R R
p53 and HER-2/neu overexpression in ovarian borderline tumors.
Gynecologic oncology 1997;65(2):218-24.
1997: Eltabbakh G H; Belinson J L; Biscotti C V
Osteosarcoma metastatic to the ovary: a case report and review of the literature.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1997;16(1):76-8.
1997: Markman M; Kennedy A; Webster K; Peterson G; Kulp B; Belinson J
Low-dose intravenous ondansetron (8 mg) plus dexamethasone: an effective regimen for the control of carboplatin-induced emesis.
Journal of cancer research and clinical oncology 1997;123(4):224-6.
1996: Connelly E; Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
Paclitaxel delivered as a 3-hr infusion with cisplatin in patients with gynecologic cancers: unexpected incidence of neurotoxicity.
Gynecologic oncology 1996;62(2):166-8.
1996: Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
Continuous subcutaneous administration of mesna to prevent ifosfamide-induced hemorrhagic cystitis.
Seminars in oncology 1996;23(3 Suppl 6):97-8.
1996: Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
Control of carboplatin-induced emesis with a fixed low dose of granisetron (0.5 mg) plus dexamethasone.
Gynecologic oncology 1996;60(3):435-7.
1996: Eltabbakh G H; Gupta M K; Belinson J L; Kennedy A W; Webster K; Paraiso M F
Comparison between Centcor CA 125 and CA 125 II assays.
European journal of gynaecological oncology 1996;17(6):504-6.
1995: Weber A M; Ziegler C; Belinson J L; Mitchinson A R; Widrich T; Fazio V
Gynecologic history of women with inflammatory bowel disease.
Obstetrics and gynecology 1995;86(5):843-7.
1995: Plummer S J; Anton-Culver H; Webster L; Noble B; Liao S; Kennedy A; Belinson J; Casey G
Detection of BRCA1 mutations by the protein truncation test.
Human molecular genetics 1995;4(10):1989-91.
1995: Kennedy A W; Peterson G; Tuason L J; Belinson J L; Webster K D
Radical hysterectomy for cervical cancer: the effect of shorter length of stay on outcome.
Cleveland Clinic journal of medicine 1995;62(3):193-7.
1995: Belinson J L; Okin C; Casey G; Ayoub A; Klein R; Hart W R; Franco K; Litt R
The familial ovarian cancer registry: progress report.
Cleveland Clinic journal of medicine 1995;62(2):129-34.

Sign-in to see more